Through AI/ML-enabled platform with a biology-first approach, Genialis looks to propel drug development, diagnostics and treatment planning Boston & Ljubljana, Slovenia – Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are […]

Funding led by Biospring Partners with participation from existing investors. BOSTON — Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures. […]

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, issued the following statement in response to a letter from Carl Icahn dated March 24, 2023: Directors and Officers (D&O) insurance and corporate indemnification are standard for Delaware companies, and support directors in making decisions in the best interests of […]

Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology VILNIUS, Lithuania and DENVER, CO – Backed by international investors, Atrandi Biosciences is establishing a direct team to support customers in the U.S. and advancing the global commercialization of its breakthrough microfluidic and single-cell analysis technologies. Following a €4.5 million funding round […]

LAUSANNE, Switzerland – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, announced today that it has completed CHF 40M in Series D1 funding. The round was led by Ernst-Göhner Stiftung Beteiligungen (EGSB), and existing investors PHC Holdings Corporation, Swiss Entrepreneurs Fund, OCCIDENT, and Redalpine participated. The funding includes a EUR […]

SAN DIEGO — Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates—two current Icahn employees, Jesse Lynn and Andrew Teno, and one former Icahn employee, Vincent Intrieri—for election to the Board […]

Semaphore is a leading provider of informatics services and laboratory information management systems (LIMS) supporting life science companies Anthony Uzzo, previously co-founder of Core Informatics and VP of R&D for Digital Science at Thermo Fisher Scientific, to join Semaphore Board as Executive Chairman NEW YORK & VICTORIA, British Columbia — Semaphore Solutions today announced a […]

SOUTH SAN FRANCISCO, Calif. — TeraPore Technologies, the developer of advanced nanofiltration membrane systems for biomanufacturing, today announced it has raised $10M in new financing. The round was led by existing investor Anzu Partners with participation from Entegris (NASDAQ: ENTG), a global leader in advanced materials science, and fellow existing investor, RA Capital Management. TeraPore […]

Following record sales growth and launch of disruptive new product CEDAR PARK, TX — VUV Analytics, Inc. announced today that it has raised $20 million in equity financing—led by existing investors S3 Ventures and New Science Ventures—bringing its total funding to over $36 million.  The announcement follows the recent launch of the company’s LUMA product […]

Investment marks Denmark’s largest seed round, funding an integrated hardware and software platform to accelerate discovery, reduce errors and eliminate cumbersome manual experimentation COPENHAGEN, Denmark — Reshape Biotech, an integrated hardware and software platform digitizing microbiology experiments, today announced an $8.1 million investment, Denmark’s largest-ever seed round. The oversubscribed investment was led by ACME Capital, with […]